Compare Novartis AG (NVS) vs Redwire Corporation (RDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Redwire Corporation — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Redwire Corporation trades at $9.66 (market cap $2.05B). The key difference: Novartis AG is far larger — about 141.6× Redwire Corporation's market cap, and Novartis AG pays a 3.17% dividend while Redwire Corporation pays none. Which is the better fit depends on your goals.
| NVS | RDW | |
|---|---|---|
Market Cap | $290.25B | $2.05B |
Sector | Health | Technology |
52-Week High | $168.62 | $25.90 |
52-Week Low | $113.50 | $5.06 |
Enterprise Value | $330.27B | $2.12B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Redwire Corporation
Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.
Read more on RDW →
